Kumar Rashmi
SEC Form 4 insider trading activity
Kumar Rashmi has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 9, 2026.
On the most recent filing, Kumar Rashmi is listed as Director at MYRIAD GENETICS INC. Inside the rolling window, Kumar Rashmi reported no open-market purchases and 1 open-market sale totaling $67K in MYGN.
Companies traded
Other insiders at MYGN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$67K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kumar Rashmi made?
Kumar Rashmi has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Kumar Rashmi trade?
Kumar Rashmi has filed SEC Form 4 disclosures for 1 company, including MYGN.
When was Kumar Rashmi's most recent SEC Form 4 filing?
Kumar Rashmi's most recent SEC Form 4 filing on Tracefour is dated Jun 9, 2026.
What is Kumar Rashmi's total buy and sell value in the current window?
Inside the rolling retention window, Kumar Rashmi bought $0 and sold $67K based on SEC Form 4 filings.
What was Kumar Rashmi's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 MYGN shares on 2026-06-08, worth $67K, per SEC Form 4 filings.